NASDAQ
Citius Oncology, Inc. (CTOR) has a free cash flow growth of 46.05% as of Friday, May 29, 2026. This represents a 659.91% increase compared to its 12-month average of -8.22%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.